Back
to sessions
Sep 27
Quick Pitch
MODERATOR(S)
Evan Osmundson, MD, PhD - Vanderbilt-Ingram Cancer Center
Gregory Videtic, MD, FASTRO, CM, FRCPC, FACR, FASTRO - Cleveland Clinic
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
05:00pm - 05:05pm ET
Phase 1 Trial of CT-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for Treatment of Ultra-Central Early-Stage Non-Small Cell Lung Cancer (NSCLC)
Speaker: Alden D'Souza, MD, MPHS - Washington University in St. Louis School of Medicine, St Louis -
05:05pm - 05:10pm ET
Prospective Study of Surface Guided Radiation Therapy (SGRT) Alone or in Combination with Fiducials for Free Breathing (FB) vs. Breath Hold (BH) Stereotactic Body Radiation Therapy (SBRT) Treatments of the Lung
Speaker: John Heinzerling, MD - Atrium Health Levine Cancer, Wake Forest School of Medicine, Southeast Radiation Oncology Group PA, Charlotte -
05:10pm - 05:15pm ET
Adebrelimab as Maintenance Therapy Following Hyperfractionated Simultaneous Integrated Boost Radiotherapy Plus Chemotherapy in Limited-Stage Small-Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Phase II Trial
Speaker: Jiayi Yu, MD, PhD - Peking University Cancer Hospital and Institute, Beijing -
05:15pm - 05:20pm ET
Optimizing Nodal Target Delineation in Limited-Stage Small Cell Lung Cancer: A Large-Scale, Multi-Institutional Study
Speaker: Xiaolong Wang, MS - Shandong Cancer Hospital and Institute, jinan -
05:20pm - 05:25pm ET
Induction Immunochemotherapy followed by Definitive Radiotherapy in Patients with Limited-Stage Small Cell Lung Cancer: A Multicenter Study
Speaker: Junxu Wen, MS - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan -
05:25pm - 05:45pm ETSpeaker: Evan Osmundson, MD, PhD - Vanderbilt-Ingram Cancer Center, Nashville